Genmab Announces Phase 3 Study Evaluating Epcoritamab in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma

  <div class="eh-ribbon">

      Trusted News Since 1995

    <span class="prof not-if-mobile-w820">A service for publishing professionals</span>
    <span class="not-if-mobile-w820">·</span>
    <span class="date">Thursday, November 5, 2020</span>
    <span class="not-if-mobile-w430">
      ·
      530,082,540
      Articles
    </span>
    <span class="not-if-mobile-w550">
      ·
      3+ Million Readers
    </span>
  </div>
</header>

<footer>
  <div class="sitemap">
    <h2 class="subheading-osc g_roboto">News Monitoring and Press Release Distribution Tools</h2>
    <div class="row-fluid">
      <div class="span3">
        <section>
          <h3>News Topics</h3>

        </section>
        <section>
          <h3>Newsletters</h3>

        </section>
      </div>
      <div class="span3">
        <section>
          <h3>Press Releases</h3>

        </section>
        <section>
          <h3>Events & Conferences</h3>

        </section>
      </div>
      <div class="span3">
        <section>
          <h3>RSS Feeds</h3>

        </section>
        <section>
          <h3>Other Services</h3>

        </section>
      </div>
      <div class="span3">
        <section>
          <h3>Questions?</h3>

        </section>
        <br/><section>

        </section>
      </div>
    </div>
  </div>
</footer>









<!--[if lt IE 9]>
<script src="/js/excanvas.min.js" type="text/javascript"></script>
<![endif]-->



<!-- Start Alexa Certify Javascript -->

<noscript/>
<!-- End Alexa Certify Javascript -->
<!--[if IE 7]>
<script type="text/javascript" src="/js/json2.js"></script>
<![endif]-->